SuMMARY We report the case of a 48-year-old woman who developed morphea-like plaques after 1 year of treatment with D-penicillamine at 250 mg daily for a seronegative erosive arthritis of rheumatoid type. The rash began as several red itchy patches on the trunk; these became thickened and shiny over about 3 months. The histological appearance was of increased dermal fibrosis with an inflammatory infiltrate round dermal capillaries. However, epidermal changes were not typical of morphea. New lesions ceased to appear within a few months of stopping penicillamine, and by 1 year all the plaques were pale and symptomless.
Late skin reactions to D-penicillamine are well known as a reason for withdrawing therapy. Some lesions such as increased friability, cutis laxa, and elastosis perforans serpiginosa are probably doserelated1 and may be due to the lathyrogenic effect of D-penicillamine inhibiting the stabilisation of cross-links in newly formed collagen.2 Indeed the drug may slow or reverse the early active skin lesions of scleroderma. On direct immunofluorescence there was a linear deposit of IgM at the dermoepidermal junction. Serum was negative against normal skin on indirect testing.
Because of the rash penicillamine was discontinued in May 1978. Erythematosus itchy areas continued to develop for several months, but after a year all patches were pale, shiny, and thickened. A biopsy at this stage showed an atrophic epidermis with thickening of the dermis and a mild perivascular chronic inflammatory infiltrate. Atrophy of the skin appendages was not seen, and there was no linear deposit of immunoglobulin in the basement membrane.
Discussion
Although the dose of penicillamine used was low (250 mg/day) it was associated with complete remission of the patient's synovitis. As the initial lesions were itchy, scratching may have contributed to the epidermal changes seen on histological study. The early itching suggested a lichenoid reaction, but the histology did not show the features seen in lichen sclerosis et atrophicans. The dermal changes consistent with morphea were a perivascular celular infiltrate, hyalinisation of the upper dermis, thickening of collagen bundles in the lower dermis, and the extension of collagen around and below the sweat glands. The features suggesting a drug reaction were the epidermal changes of focal hyperkeratosis and parakeratosis with spongiosis and focal basal cell liquefaction, the predominance of eosinophils in the dermal perivascular infiltrate, the uneven diameter, of collagen bundles in the lower dermis, and the linear immunofluorescence to IgM at the dermoepidermal junction. These features were present on the initial biopsy but not 1 year after withdrawal of penicillamine. It is possible that the deposition of immunoglobulin at the dermoepidermal junction is a feature of penicillamine reactions in general. Kirby et al.7 have reported 4 cases with a granular pattern of immunofluorescence to immunoglobulin, but there has been no systematic study.
It is concluded that a rash reminiscent of morphea, with increased dermal collagen, may occur as a late skin reaction to D-penicillamine.
